Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
SGLT2 inhibitor
Proteasome inhibitor.
5-HT1B/1D agonist.
11β-HSD1 inhibitor.
Endogenous tachykinin peptide, involved in infl...
5-HT1A agonist, 5-HT2A antagonist.
Laminin-derived hexapeptide.
T-type Ca2+ and voltage-gated Na+ channel block...
TNKS1/2 inhibitor.
ITC found in cruciferous vegetables.
Polyphenolic compound present in black tea.
PDGFR and c-Kit inhibitor.
MET, FGFR, PDGFR inhibitor.
Thiazolidinone macrolide found in the Red Sea s...
Glutathione-ITC conjugate, antioxidant.
Nitroimidazole, binds DNA; nucleic acid synthes...
Casein kinase 2 inhibitor.
PI3K inhibitor.
Polyphenol found in Camilla sinensis; HIV integ...
Acyclic nucleotide (adenosine) analog, adefovir...